Erratum: Symptomatic and Palliative Care for Stroke Survivors [J GEN INTERN MED, DOI 10.1007/s11606-011-1966-4];Symptomatic and palliative care for stroke survivors

Journal of General Internal Medicine

Volumn 27, Issue 7, 2012, Pages 853-860

  Creutzfeldt, Claire J ^a   Holloway, Robert G ^b   Walker, Melanie ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

palliative care; stroke; symptom management

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; BISACODYL; BOTULINUM TOXIN; BOTULINUM TOXIN A; CARBAMAZEPINE; CITALOPRAM; DANTROLENE; DOCUSATE SODIUM; ETIRACETAM; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; MACROGOL; MAGNESIUM OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PREGABALIN; REBOXETINE; SENNA EXTRACT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; STEROID; TIZANIDINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ANTICONVULSANT THERAPY; ANXIETY DISORDER; BEHAVIOR THERAPY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAREGIVER; CENTRAL POSTSTROKE PAIN; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CONFUSION; CONSTIPATION; CONTROLLED CLINICAL TRIAL (TOPIC); DEPRESSION; DIARRHEA; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; EMOTIONAL DEPRIVATION; EPILEPSY; EVIDENCE BASED MEDICINE; EXERCISE; FATIGUE; FECES INCONTINENCE; HEALTH CARE PERSONNEL; HEMIPLEGIA; HEMIPLEGIC SHOULDER PAIN; HUMAN; HYPONATREMIA; INCONTINENCE; LIBIDO DISORDER; LIVER TOXICITY; MEDICAL SPECIALIST; MENTAL DISEASE; MORTALITY; NEUROMUSCULAR ELECTRICAL STIMULATION; NEUROPATHIC PAIN; PALLIATIVE THERAPY; PHYSIOTHERAPY; POSITIVE END EXPIRATORY PRESSURE; POST STROKE DEPRESSION; POSTSTROKE EPILEPSY; PRACTICE GUIDELINE; QUALITY OF LIFE; RANGE OF MOTION; REVIEW; RISK REDUCTION; SECONDARY PREVENTION; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SHOULDER PAIN; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; SOMNOLENCE; SPASTICITY; SPIRITUAL CARE; STROKE; STROKE PATIENT; SURVIVOR; SYMPTOM; SYSTEMATIC REVIEW; TENSION HEADACHE; TREATMENT OUTCOME; TREMOR; URINE INCONTINENCE; WEAKNESS;

EID: 84862668789     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-014-2876-z     Document Type: Erratum

References (67)

1. AHA/ASA. Heart Disease and Stroke Statistics - 2010 Update; 2010.
2. HP Adams Jr G del Zoppo MJ Alberts, et al. 2007 Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists Stroke 38 1655 1711 17431204 10.1161/STROKEAHA.107.181486
3. LB Morgenstern JC Hemphill 3rd C Anderson, et al. 2010 Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 41 2108 2129 20651276 10.1161/STR.0b013e3181ec611b
4. P Langhorne F Coupar A Pollock 2009 Motor recovery after stroke: a systematic review Lancet Neurol 8 741 754 19608100 10.1016/S1474-4422(09)70150-4
5. P Langhorne J Bernhardt G Kwakkel 2011 Stroke rehabilitation Lancet 377 1693 1702 21571152 10.1016/S0140-6736(11)60325-5
6. PW Duncan R Zorowitz B Bates, et al. 2005 Management of Adult Stroke Rehabilitation Care: a clinical practice guideline Stroke 36 e100 e143 16120836 10.1161/01.STR.0000180861.54180.FF
7. T Stevens SA Payne C Burton J Addington-Hall A Jones 2007 Palliative care in stroke: a critical review of the literature Palliat Med 21 323 331 17656409 10.1177/0269216307079160 1:STN:280:DC%2BD2svjvVamtg%3D%3D
8. Edlund WGG, So Y, Franklin G. Clinical Practice Guideline Process Manual. online; 2004.
9. WHO. Available at: http://www.who.int/cancer/palliative/definition/en/. Accessed 12/07/2011.
10. E Kehayia N Korner-Bitensky F Singer, et al. 1997 Differences in pain medication use in stroke patients with aphasia and without aphasia Stroke 28 1867 1870 9341686 10.1161/01.STR.28.10.1867 1:STN:280:DyaK1c%2FgtVyqsQ%3D%3D
11. AC Jönsson I Lindgren B Hallström B Norrving A Lindgren 2006 Prevalence and intensity of pain after stroke: a population based study focusing on patients' perspectives J Neurol Neurosurg Psychiatry 77 590 595 16354737 10.1136/jnnp.2005.079145
12. H Klit NB Finnerup TS Jensen 2009 Central post-stroke pain: clinical characteristics, pathophysiology, and management Lancet Neurol 8 857 868 19679277 10.1016/S1474-4422(09)70176-0
13. G Leijon J Boivie 1989 Central post-stroke pain-a controlled trial of amitriptyline and carbamazepine Pain 36 27 36 2465530 10.1016/0304-3959(89) 90108-5 1:STN:280:DyaL1M7ksVKgtQ%3D%3D
14. T Saarto PJ Wiffen 2007 Antidepressants for neuropathic pain Cochrane Database Syst Rev 4 CD005454 17943857
15. K Vestergaard G Andersen H Gottrup BT Kristensen TS Jensen 2001 Lamotrigine for central poststroke pain: a randomized controlled trial Neurology 56 184 190 11160953 10.1212/WNL.56.2.184 1:CAS:528:DC%2BD3MXoslGitg%3D%3D
16. JS Kim G Bashford TK Murphy A Martin V Dror R Cheung 2011 Safety and efficacy of pregabalin in patients with central post-stroke pain Pain 152 1018 1023 21316855 10.1016/j.pain.2010.12.023 1:CAS:528:DC%2BC3MXkvVWntLc%3D
17. MG Serpell Neuropathic pain study group 2002 Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial Pain 99 557 566 12406532 10.1016/S0304-3959(02)00255-5 1:CAS:528:DC%2BD38Xot1ait74%3D
18. A Frese IW Husstedt EB Ringelstein S Evers 2006 Pharmacologic treatment of central post-stroke pain Clin J Pain 22 252 260 16514325 10.1097/01.ajp. 0000173020.10483.13 1:STN:280:DC%2BD287is1WjsA%3D%3D
19. I Lindgren AC Jonsson B Norrving A Lindgren 2007 Shoulder pain after stroke: a prospective population-based study Stroke 38 343 348 17185637 10.1161/01.STR.0000254598.16739.4e
20. RP Van Peppen G Kwakkel S Wood-Dauphinee HJ Hendriks PJ Van der Wees J Dekker 2004 The impact of physical therapy on functional outcomes after stroke: what's the evidence? Clin Rehabil 18 833 862 15609840 10.1191/0269215504cr843oa
21. JA Singh PM Fitzgerald 2010 Botulinum toxin for shoulder pain Cochrane Database Syst Rev 9 CD008271 20824874
22. YH Koog SS Jin K Yoon BI Min 2010 Interventions for hemiplegic shoulder pain: systematic review of randomised controlled trials Disabil Rehabil 32 282 291 20055567 10.3109/09638280903127685
23. GE Gamble E Barberan HU Laasch D Bowsher PJ Tyrrell AK Jones 2002 Poststroke shoulder pain: a prospective study of the association and risk factors in 152 patients from a consecutive cohort of 205 patients presenting with stroke Eur J Pain 6 467 474 12413435 10.1016/S1090-3801(02)00055-1
24. E Lapeyre JB Kuks WJ Meijler 2010 Spasticity: revisiting the role and the individual value of several pharmacological treatments NeuroRehabilitation 27 193 200 20871149
25. LC Shaw CI Price FM van Wijck, et al. 2011 Botulinum Toxin for the Upper Limb After Stroke (BoTULS) Trial: Effect on Impairment, Activity Limitation, and Pain Stroke 42 1371 1379 21415398 10.1161/STROKEAHA.110.582197 1:CAS:528:DC%2BC3MXltFyrtb0%3D
26. P Appelros 2006 Prevalence and predictors of pain and fatigue after stroke: a population-based study Int J Rehabil Res 29 329 333 17106351 10.1097/MRR.0b013e328010c7b8
27. GE Mead C Graham P Dorman SK Bruins SC Lewis MS Dennis PA Sandercock 2011 UK Collaborators of IST. Fatigue after stroke: baseline predictors and influence on survival. Analysis of data from UK patients recruited in the International Stroke Trial PLoS One 6 e16988 21445242 10.1371/journal.pone. 0016988 1:CAS:528:DC%2BC3MXktVOgs7w%3D
28. C Winward C Sackley Z Metha PM Rothwell 2009 A population-based study of the prevalence of fatigue after transient ischemic attack and minor stroke Stroke 40 757 761 19131658 10.1161/STROKEAHA.108.527101 1:CAS:528: DC%2BD1MXhvVSku7o%3D
29. NA Flinn JE Stube 2010 Post-stroke fatigue: qualitative study of three focus groups Occup Ther Int 17 81 91 19787634
30. McGeough E, Pollock A, Smith LN, et al. Interventions for post-stroke fatigue. Cochrane Database Syst Rev 2009:CD007030.
31. A Brioschi S Gramigna E Werth, et al. 2009 Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients Eur Neurol 62 243 249 19672078 10.1159/000232927 1:CAS:528:DC%2BD1MXhtVygurbO
32. Peuckmann V, Elsner F, Krumm N, Trottenberg P, Radbruch L. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev 2010:CD006788.
33. H Nakayama HS Jorgensen PM Pedersen HO Raaschou TS Olsen 1997 Prevalence and risk factors of incontinence after stroke. The Copenhagen Stroke Study Stroke 28 58 62 8996489 10.1161/01.STR.28.1.58 1:STN:280:DyaK2s7kvFKrsw%3D%3D
34. Thomas LH, Cross S, Barrett J, et al. Treatment of urinary incontinence after stroke in adults. Cochrane Database Syst Rev 2008:CD004462.
35. SS Rao JT Go 2010 Update on the management of constipation in the elderly: new treatment options Clin Interv Aging 5 163 171 20711435 10.2147/CIA.S8100
36. CF Bladin AV Alexandrov A Bellavance, et al. 2000 Seizures after stroke: a prospective multicenter study Arch Neurol 57 1617 1622 11074794 10.1001/archneur.57.11.1617 1:STN:280:DC%2BD3M%2FjsVKiug%3D%3D
37. S Berges T Moulin E Berger, et al. 2000 Seizures and epilepsy following strokes: recurrence factors Eur Neurol 43 3 8 10601801 10.1159/000008120 1:STN:280:DC%2BD3c%2FmvFChsw%3D%3D
38. Kwan J, Wood E. Antiepileptic drugs for the primary and secondary prevention of seizures after stroke. Cochrane Database Syst Rev 2010:CD005398
39. P Ryvlin A Montavont N Nighoghossian 2006 Optimizing therapy of seizures in stroke patients Neurology 67 S3 S9 17190919 10.1212/WNL.67.12-suppl-4.S3
40. E Perucca T Tomson 2011 The pharmacological treatment of epilepsy in adults Lancet Neurol 10 5 446 456 21511198 10.1016/S1474-4422(11)70047-3 1:CAS:528:DC%2BC3MXlt1SlsL8%3D
41. Y Tamam L Tamam E Akil A Yasan B Tamam 2008 Post-stroke sexual functioning in first stroke patients Eur J Neurol 15 660 666 18484994 10.1111/j.1468-1331.2008.02184.x 1:STN:280:DC%2BD1cvht1amtw%3D%3D
42. DD Kautz 2007 Hope for love: practical advice for intimacy and sex after stroke Rehabil Nurs 32 95 103 17514993 10.1002/j.2048-7940.2007.tb00160.x
43. B Silver S McCarthy M Lu, et al. 2009 Sildenafil treatment of subacute ischemic stroke: a safety study at 25-mg daily for 2 weeks J Stroke Cerebrovasc Dis 18 381 383 19717023 10.1016/j.jstrokecerebrovasdis.2009.01.007
44. DM Hermann CL Bassetti 2009 Sleep-related breathing and sleep-wake disturbanes in ischemic stroke Neurology 73 1313 1322 19841384 10.1212/WNL.0b013e3181bd137c
45. W Chan SB Coutts P Hanly 2010 Sleep apnea in patients with transient ischemic attack and minor stroke: opportunity for risk reduction of recurrent stroke? Stroke 41 2973 2975 20966412 10.1161/STROKEAHA.110.596759
46. Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2008:CD003437.
47. Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev 2008:CD003689.
48. F Chollet J Tardy JF Albucher, et al. 2011 Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial Lancet Neurol 10 123 130 21216670 10.1016/S1474-4422(10)70314-8 1:CAS:528:DC%2BC3MXpsFOhtw%3D%3D
49. L Rampello A Alvano S Chiechio R Raffaele I Vecchio M Malaguarnera 2005 An evaluation of efficacy and safety of reboxetine in elderly patients affected by "retarded" post-stroke depression. A random, placebo-controlled study Arch Gerontol Geriatr 40 275 285 15814161 10.1016/j.archger.2004.09.004 1:CAS:528:DC%2BD2MXjt1Kjtr0%3D
50. PH Mitchell RC Veith KJ Becker, et al. 2009 Brief psychosocial-behavioral intervention with antidepressant reduces poststroke depression significantly more than usual care with antidepressant: living well with stroke: randomized, controlled trial Stroke 40 3073 3078 19661478 10.1161/STROKEAHA.109.549808 1:CAS:528:DC%2BD1MXhtVSisLrI
51. CS Castillo SE Starkstein JP Fedoroff TR Price RG Robinson 1993 Generalized anxiety disorder after stroke J Nerv Ment Dis 181 100 106 8426166 10.1097/00005053-199302000-00005 1:STN:280:DyaK3s7kslyjsw%3D%3D
52. G Andersen K Vestergaard L Lauritzen 1994 Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram Stroke 25 1099 1104 8202964 10.1161/01.STR.25.6.1099 1:STN:280: DyaK2c3mt1Wjtw%3D%3D
53. Lonergan E, Britton AM, Luxenberg J, Wyller T. Antipsychotics for delirium. Cochrane Database Syst Rev 2007:CD005594.
54. House AO, Hackett ML, Anderson CS, Horrocks JA. Pharmaceutical interventions for emotionalism after stroke. Cochrane Database Syst Rev 2010:CD003690.
55. Dextromethorphan/Quinidine (nuedexta) for pseudobulbar affect. Med Lett Drugs Ther. 2011;53:46-47
56. ET Van den Heuvel LP de Witte LM Schure R Sanderman 2001 Meyboom-de Jong B. Risk factors for burn-out in caregivers of stroke patients, and possibilities for intervention Clin Rehabil 15 669 677 11777097 10.1191/0269215501cr446oa
57. B Han WE Haley 1999 Family caregiving for patients with stroke. Review and analysis Stroke 30 1478 1485 10390326 10.1161/01.STR.30.7.1478 1:STN:280:DyaK1MzhvFWitQ%3D%3D
58. L Kalra A Evans I Perez, et al. 2004 Training carers of stroke patients: randomised controlled trial BMJ 328 1099 15130977 10.1136/bmj.328.7448.1099
59. C Puchalski B Ferrell R Virani, et al. 2009 Improving the quality of spiritual care as a dimension of palliative care: the report of the Consensus Conference J Palliat Med 12 885 904 19807235 10.1089/jpm.2009.0142
60. JW Ehman BB Ott TH Short RC Ciampa J Hansen-Flaschen 1999 Do patients want physicians to inquire about their spiritual or religious beliefs if they become gravely ill? Arch Intern Med 159 1803 1806 10448785 10.1001/archinte.159. 15.1803 1:STN:280:DyaK1Mzns1Sitw%3D%3D
61. TE Quill B Lo DW Brock 1997 Palliative options of last resort: a comparison of voluntarily stopping eating and drinking, terminal sedation, physician-assisted suicide, and voluntary active euthanasia JAMA 278 2099 2104 9403426 10.1001/jama.1997.03550230075041 1:STN:280:DyaK1c%2FmsFKrtg%3D%3D
62. RG Robinson SK Schultz C Castillo, et al. 2000 Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study Am J Psychiatry 157 351 359 10698809 10.1176/appi.ajp.157.3.351 1:STN:280:DC%2BD3c7mtl2gsw%3D%3D
63. L Wiart H Petit PA Joseph JM Mazaux M Barat 2000 Fluoxetine in early poststroke depression: a double-blind placebo-controlled study Stroke 31 1829 1832 10926942 10.1161/01.STR.31.8.1829 1:CAS:528:DC%2BD3cXlvFynsrc%3D
64. LT Li SH Wang HY Ge J Chen SW Yue M Yu 2008 The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) and fluoxetine on post- stroke depression J Altern Complement Med 14 841 846 18721085 10.1089/acm.2008.0010
65. S Fruehwald E Gatterbauer P Rehak U Baumhackl 2003 Early fluoxetine treatment of post-stroke depression-a three-month double-blind placebo-controlled study with an open-label long-term follow up J Neurol 250 347 351 12638027 10.1007/s00415-003-1014-3 1:CAS:528:DC%2BD3sXjslSrtL0%3D
66. V Murray M von Arbin A Bartfai, et al. 2005 Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression J Clin Psychiatry 66 708 716 15960563 10.4088/JCP.v66n0606 1:CAS:528:DC%2BD2MXmtlKqtL0%3D
67. RG Robinson RE Jorge K Clarence-Smith 2008 Double-blind randomized treatment of poststroke depression using nefiracetam J Neuropsychiatry Clin Neurosci 20 178 184 18451188 10.1176/appi.neuropsych.20.2.178 1:CAS:528:DC%2BD1cXmsFKhtLk%3D